Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01404962

Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children

Haemophilus Influenzae Type B Infection Clinical Trial

Official title:
A Post Marketing Surveillance Study to Monitor the Reactogenicity and Safety of Vaxem™Hib When Administered According to the Prescribing Information in Korea

Clinical Trial Summary

This is a multicenter, post marketing surveillance study which aims to evaluate the safety profile of haemophilus influenza type b vaccine when administered to Korean children according to the product insert.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01404962
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 4
Start date August 2011
Completion date July 2012
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04056728 - A Phase IV Study to Assess the Safety of EupentaTM Inj Phase 4
Not yet recruiting NCT04073459 - Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants Phase 2
Completed NCT02094833 - DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants Phase 3
Completed NCT00654901 - Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ Phase 3
Completed NCT03208101 - A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults Phase 1
Not yet recruiting NCT05952596 - A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults Phase 1
Completed NCT03870061 - Evaluation of an Infant Immunization Encouragement Program in Nigeria N/A
Completed NCT04978818 - Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study) Phase 4
Not yet recruiting NCT03341195 - Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan N/A
Completed NCT04177485 - Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda N/A
Recruiting NCT02821195 - Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine Phase 3
Not yet recruiting NCT05457946 - Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series Phase 2/Phase 3